LU87334A1 - Suppositoires a base de calcitonine - Google Patents

Suppositoires a base de calcitonine Download PDF

Info

Publication number
LU87334A1
LU87334A1 LU87334A LU87334A LU87334A1 LU 87334 A1 LU87334 A1 LU 87334A1 LU 87334 A LU87334 A LU 87334A LU 87334 A LU87334 A LU 87334A LU 87334 A1 LU87334 A1 LU 87334A1
Authority
LU
Luxembourg
Prior art keywords
calcitonin
suppository
suppositories
acid
taurocholic acid
Prior art date
Application number
LU87334A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87334A1 publication Critical patent/LU87334A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Epoxy Compounds (AREA)
LU87334A 1987-09-15 1988-09-12 Suppositoires a base de calcitonine LU87334A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8721700 1987-09-15
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB8801991 1988-01-29
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB8805068 1988-03-03
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
LU87334A1 true LU87334A1 (fr) 1989-07-07

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87334A LU87334A1 (fr) 1987-09-15 1988-09-12 Suppositoires a base de calcitonine

Country Status (26)

Country Link
US (1) US5149537A (no)
JP (1) JPH01228919A (no)
KR (1) KR970003052B1 (no)
AT (1) AT396424B (no)
AU (1) AU614769B2 (no)
BE (1) BE1001937A3 (no)
CA (1) CA1330417C (no)
CH (1) CH677320A5 (no)
CY (1) CY1763A (no)
DE (1) DE3830245A1 (no)
DK (1) DK509888A (no)
ES (1) ES2012119A6 (no)
FI (1) FI87889C (no)
FR (1) FR2620331B1 (no)
GB (1) GB2209670B (no)
HK (1) HK19394A (no)
HU (1) HU203204B (no)
IL (1) IL87747A (no)
LU (1) LU87334A1 (no)
MY (1) MY103611A (no)
NL (1) NL8802274A (no)
NO (1) NO175518C (no)
NZ (1) NZ226162A (no)
PH (1) PH24766A (no)
PT (1) PT88491B (no)
SE (1) SE8803222L (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
BR9912395A (pt) 1998-07-24 2001-10-16 Seo Hong Yoo Preparação de formas de dosagem de solução clara aquosa com ácidos biliares
WO2001056547A2 (en) * 2000-02-04 2001-08-09 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
PT1651249E (pt) 2003-07-23 2012-12-21 Novartis Ag Uso de calcitonina em osteoartrite
US8173627B2 (en) * 2004-08-30 2012-05-08 Seo Hong Yoo Neuroprotective effect of solubilized UDCA in focal ischemic model
EP1809330B1 (en) * 2004-10-15 2011-04-27 Seo Hong Yoo Compositions for reducing toxicity of cisplatin, carboplatin, and oxaliplatin
KR101358078B1 (ko) * 2004-11-01 2014-02-06 주식회사 유스팜인터내셔널 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
KR102287352B1 (ko) * 2015-06-30 2021-08-06 (주)아모레퍼시픽 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
FI884191A0 (fi) 1988-09-13
NO175518B (no) 1994-07-18
GB2209670B (en) 1991-05-08
FI884191A (fi) 1989-03-16
FI87889C (fi) 1993-03-10
HU203204B (en) 1991-06-28
GB2209670A (en) 1989-05-24
ATA224788A (de) 1993-01-15
FR2620331A1 (fr) 1989-03-17
KR890004680A (ko) 1989-05-09
KR970003052B1 (ko) 1997-03-14
NO175518C (no) 1994-10-26
SE8803222D0 (sv) 1988-09-13
US5149537A (en) 1992-09-22
AT396424B (de) 1993-09-27
PH24766A (en) 1990-10-01
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
NO884053L (no) 1989-03-16
HK19394A (en) 1994-03-18
CY1763A (en) 1994-07-15
SE8803222L (sv) 1989-03-16
PT88491A (pt) 1988-10-01
NZ226162A (en) 1991-03-26
FI87889B (fi) 1992-11-30
MY103611A (en) 1993-08-28
DK509888D0 (da) 1988-09-13
BE1001937A3 (fr) 1990-04-17
JPH01228919A (ja) 1989-09-12
GB8821429D0 (en) 1988-10-12
DK509888A (da) 1989-03-16
DE3830245A1 (de) 1989-03-30
PT88491B (pt) 1992-11-30
NO884053D0 (no) 1988-09-13
NL8802274A (nl) 1989-04-03
CH677320A5 (no) 1991-05-15
IL87747A0 (en) 1989-02-28
ES2012119A6 (es) 1990-03-01
FR2620331B1 (fr) 1991-11-08
IL87747A (en) 1992-05-25
HUT47864A (en) 1989-04-28
AU614769B2 (en) 1991-09-12

Similar Documents

Publication Publication Date Title
BE1001937A3 (fr) Suppositoire a base de calcitonine.
EP1467724B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
FR2537980A1 (fr) Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
HU211544A9 (en) Transdermal composition
FR2642650A1 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines
CN1168635A (zh) 新的抗血栓形成的制剂及制备方法和用途
FR2764800A1 (fr) Composition pharmaceutique solide contenant des derives de benzofuranne
CA2123232C (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
CA2004092A1 (fr) Amincissants topiques contenant des derives cafeines carboxyliques neutralises par des bases organiques et preparations utiles dans le traitement de la cellulite
EP3615036A1 (fr) Extrait de 20-hydroxyecdysone de qualité pharmaceutique, son utilisation et sa préparation
EP0601911B1 (fr) Acylaminoacides obtenus par l'acylation d'hydrolysats de protéines et compositions anti-microbiennes, antiparasitaires ou cosmétiques en contenant
LU86901A1 (fr) Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
FR2723093A1 (fr) Esters d'acyle d'acides amines achiraux du glanciclovir
EP0087378B1 (fr) Ethers-oximes d'alcoylaminoalcools comme médicaments, produits nouveaux et procédés pour leur préparation
BE1005115A5 (fr) Compositions pharmaceutiques contenant des derives de furanne.
FR2742660A1 (fr) Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
EP0846688A1 (fr) Nouveaux dérivés de l'imidazoline ayant une affinité pour les récepteurs aux imidazolines
BE897843A (fr) Derives biologiquement actifs de 2, 5-piperazinediones, procede pour leur preparation et compositions pharmaceutique en contenant
FR2510112A1 (fr) Nouveaux derives du 2-oxo-pyrid-3-yl ou piperidin-3-yl indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
EP0286515A1 (fr) Nouvelles amines tricycliques dérivées du tétrahydro-5,6,7,8 naphto [2,3b] dihydro-2,3 furanne, et du tétrahydro-6,7,8,9 5H-benzocyclohepta [2,3b] dihydro-2,3 furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
BE898430A (fr) Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation.
FR2534808A1 (fr) Composition antivirale contenant du 2-(4-chlorophenoxymethyl)-3,3-dimethyl-1-(1,2,4-triazole-1-yl)-2-butanol
EP1358159B1 (fr) Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
FR2705895A1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.